Table 3.
Animals | Stroke model | Time of treatment | Routes of exosome delivery | Exosome modifications | Proposed mechanisms | Ref |
Rat | 50 min tMCAO | 3 hours after ischaemia | Intravenously | No | Anti-inflammation, anti-apoptosis | 155 |
Rat | tMCAO | Immediately after ischaemia | Tail vein | Enriched with miR-30d-5p | Reduce autophagy and inflammation, and promote microglia M2 polarisation | 105 |
Rat | tMCAO | Not mentioned | Intravenously | Enriched with miR-126 | Promote neurogenesis, angiogenesis, anti-inflammation | 104 |
Rat | 1 hour tMCAO | 3 days before ischaemia | Lateral cerebral ventricle injection | Loaded with pigment epithelium-derived factor | Promote autophagy | 156 |
tMCAO, transient middle cerebral artery occlusion.